Shock therapy: high norepinephrine doses linked to death risk

NCT ID NCT05032261

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 100 ICU patients with circulatory shock who received norepinephrine, a drug that raises blood pressure. Researchers wanted to see if a certain dose was linked to higher death rates within 5 days. They also studied how long patients needed the drug and the total amount given. The goal was to find a dose limit where more medicine no longer helps.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRCULATORY COLLAPSE AND SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Shock

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Nîmes - Hôpital Universitaire Carémeau

    Nîmes, 30029, France